期刊文献+

盐酸索他洛尔脉冲微丸体外释放特性研究 被引量:1

Release Behavior and Model Fitting of Sotalol Hydrochloride Pulsatile Pellets
原文传递
导出
摘要 目的研究盐酸索他洛尔脉冲微丸的体外释放特性,根据本类脉冲释放曲线的关键点的比较指导处方优化。方法采用多种数学模型拟合释放曲线,并对各曲线回归方程进行拟合优度测验;同时利用曲线的载荷信息,通过曲线的生长速度函数的一阶和二阶导数得到曲线变化的数学突变点。结果Logistic拟合释放曲线的拟合优度x2及AIC最小,r2最接近于1,说明Logistic拟合效果最好;同时得到比较本类型释放曲线的3个关键点t1=-(lnc2+1.317)/c3,tm=(lnc2)/c3,t2=(1.317-lnc2)/c3,将曲线分为迟释期(0~t1)、突释期(t1~t2)以及减速释放期(t2~∞)。结论通过本类型的曲线拟合及推导,提出可以用模拟曲线的关键点评价不同处方的释放特性,从而指导及优化处方并作进一步研究。 OBJECTIVE To investigate release behavior of sotalol hydrochloride pulsatile pellets in vitro, and to realize pulsatile release mechanism and optimize formulation. METHODS The release profile of sotalol hydrochloride pellets were fitted and compared by employing different kinds of mathematic model. For fitting a good curve regression equation, the adopting x2 and AIC test were used. By first and second derivative of velocity function from growth process of logistic curve, the yielding points displaying the variety of curve were obtained and compared. RESULTS The Logistic model was the best one for fitting the pulsatile release profiles among the several mathematical models. The three key-points were obtained by Logistic curve: t1=-(lnc2+1.317)/c3,tm=(lnc2)/c3,t2=(1.317-lnc2)/c3. And using two yielding points of the velocity function from the growth process of Logistic model, the release profile was divided into time-delayed release (0-t1), rupturing release (t1-t2), decelerating release (t2~∞). CONCLUSION The regression and prediction indicated that, we can employ the yielding points of the model curve to evaluate the release properties from different formulations. The optimization of the formulation could be guided by the comparison of three key-points.
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第5期358-361,共4页 Chinese Pharmaceutical Journal
关键词 释放曲线 模型拟合 脉冲微丸 LOGISTIC 索他洛尔 release profile regression pulsatilepellets Logistic sotalol
  • 相关文献

参考文献7

  • 1COSTA F O, SOUSA J J S, PAlS A A C C, et al. Comparison of dissolution profiles of Ibuprofen pellets [J]. J Controlled Release, 2003, 89 (2): 199-212.
  • 2SIEWERT M, WEINANDY L, WHITEMAN D, et al. Typical variability and evaluation of sources of variability in drug dissolution testing [J]. Eur J Pharm Biopharm, 2002, 53 (2): 9-14.
  • 3朱颖,程宁,王雨青,郑梁元.硫酸沙丁胺醇脉冲微丸释放特性的模型拟合和比较[J].中国医药工业杂志,2006,37(1):20-22. 被引量:7
  • 4LEMMER B. Circadian rhythms and drug delivery [J]. J Controlled Release, 1991, 16(1-2): 63-74.
  • 5FOX K M, MULCAH D A. Circadian rhythms in cardiovascular function[J].PostgradMedJ, 1991, 67 (Suppl5): 33-36.
  • 6YAMAOKA K, NAKAGAWA T, UNO T. Application of akaike's information criterion (AIC) , in the evaluation of linear pharmacokinetic equations [J]. J Pharmaeokin Biopharm, 1978, 6 (2): 165-175.
  • 7陈盛君,朱家壁.盐酸地尔硫延迟缓释微丸组合系统释药行为的研究及其数学解析[J].药学学报,2005,40(7):606-610. 被引量:9

二级参考文献8

  • 1[1]Mauger JW,Chilko D,Howard S.On the analysis of the dissolution data[J].Drug Dev Ind Pharm,1986,12 (7):969-992.
  • 2[2]Polli JE,Rekhi GS,Augsburger LL,et al.Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets[J].JPharm Sci,1997,86 (6):690-700.
  • 3[3]Sathe PM,Tsong Y,Shah VP.In-vitro dissolution profile comparison:statistics and analysis,model dependent approach[J].Pharm Res,1996,13 (12):1799-1803.
  • 4[4]Moore JW,Flanner HH.Mathematical comparison of dissolution profiles [J].Pharm Technol,1996,20 (6):64-74.
  • 5[5]Podczeck F.Comparison of in vitro dissolution profiles by calculating mean dissolution time (MDT) or mean residence time (MRT) [J].Int J Pharm,1993,97 (1-3):93-100.
  • 6[6]Shah VP,Tsong Y,Sathe P,et al.In vitro dissolution profile comparison--statistics and analysis of the similarity factor,f2 [J].Pharm Res,1998,15 (6):889-896.
  • 7张静,平其能.口服择时释药系统[J].药学进展,1999,23(5):265-269. 被引量:27
  • 8张宁,朱家壁.盐酸地尔硫延迟起释型缓释片的研制[J].药学学报,2002,37(9):724-727. 被引量:11

共引文献14

同被引文献5

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部